{"id":4638,"date":"2024-09-06T12:04:53","date_gmt":"2024-09-06T02:04:53","guid":{"rendered":"\/eu-uk\/?p=4638"},"modified":"2024-09-06T12:04:53","modified_gmt":"2024-09-06T02:04:53","slug":"first-sales-of-striate-in-new-and-significant-market-of-canada","status":"publish","type":"post","link":"\/eu-uk\/blog\/2024\/09\/06\/first-sales-of-striate-in-new-and-significant-market-of-canada\/","title":{"rendered":"First Sales of Striate+\u2122 in New and Significant Market of Canada"},"content":{"rendered":"<p>Orthocell has today announced global distribution partner BioHorizons has recorded a fast transition to first sales of Striate+\u2122 in the key market of Canada, following regulatory approval in early July. Striate+ can now be used in Canada in dental guided bone and tissue regeneration procedures.<\/p>\n<p>The Canadian market alone is estimated to be worth AU$60 million, with the global market opportunity for Striate estimated to be in excess of AU$1 billion.<\/p>\n<p>Orthocell Managing Director, Paul Anderson, said:<\/p>\n<p>\u201cCommencement of sales in Canada is further validation of Orthocell\u2019s expanding global footprint. Our valued partner BioHorizons has executed a rapid transition from approval to first sales. This reaffirms the high-quality nature of our product and partnership. Once Singapore and Brazil applications are approved, Striate+ will be available for use in guided bone and tissue repair in seven large and attractive markets. And we will continue to accelerate approvals in what is a significant AU$1 billion annual global market.\u201d<\/p>\n<p><a href=\"https:\/\/bit.ly\/OCC-Striate-Canada\">Click here to read the ASX release.<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Orthocell has today announced global distribution partner BioHorizons has recorded a fast transition to first sales of Striate+\u2122 in the key market of Canada.<\/p>\n","protected":false},"author":2,"featured_media":4639,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false,"footnotes":""},"categories":[2],"tags":[],"class_list":["post-4638","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company-news"],"aioseo_notices":[],"_links":{"self":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4638","targetHints":{"allow":["GET"]}}],"collection":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/comments?post=4638"}],"version-history":[{"count":1,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4638\/revisions"}],"predecessor-version":[{"id":4640,"href":"\/eu-uk\/wp-json\/wp\/v2\/posts\/4638\/revisions\/4640"}],"wp:featuredmedia":[{"embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/media\/4639"}],"wp:attachment":[{"href":"\/eu-uk\/wp-json\/wp\/v2\/media?parent=4638"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/categories?post=4638"},{"taxonomy":"post_tag","embeddable":true,"href":"\/eu-uk\/wp-json\/wp\/v2\/tags?post=4638"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}